The Scientist

» Darwin, developmental biology and immunology

Most Recent

image: Opinion: We Have Been Naive About Naive T Cells

Opinion: We Have Been Naive About Naive T Cells

By Theo van den Broek, José A.M. Borghans, and Femke van Wijk | April 6, 2018

Human naive T cells are far more heterogeneous than has long been appreciated, having implications for vaccine strategies.

2 Comments

image: Ruth Nussenzweig, Malaria Researcher, Dies

Ruth Nussenzweig, Malaria Researcher, Dies

By Jim Daley | April 6, 2018

The microbiologist’s research led to the development of the first human malaria vaccine.

0 Comments

Mice treated with an immunostimulant had better outcomes when researchers blocked the expression of TNFR2, a compound that helps tumors evade immune attack.

0 Comments

In the presence of cytosolic DNA, cancer cells activate antiviral pathways that disguise them as immune cells.

0 Comments

Errors in segregation during cell division can lead to inflammation in daughter cells.

0 Comments

image: Image of the Day: New Neurons

Image of the Day: New Neurons

By The Scientist Staff | March 28, 2018

Scientists discover a molecular factor that allows them to follow neurons from birth to maturity.

0 Comments

image: Tadpoles Keep Eating Because They Don’t Feel Full

Tadpoles Keep Eating Because They Don’t Feel Full

By Catherine Offord | March 28, 2018

Baby frogs don’t develop the neural circuitry responsible for feeding inhibition until they begin metamorphosing into adults. 

0 Comments

The drugs’ disruption of the microbiome makes a subsequent flavivirus infection more severe.

0 Comments

image: Image of the Day: Morphing Cells

Image of the Day: Morphing Cells

By The Scientist Staff | March 27, 2018

By removing a single gene, researchers change the developmental fate of tumor cells in mice.  

0 Comments

A study finds that the vaccine’s effects wear off as a person ages, suggesting a need for booster shots.

1 Comment

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Anheuser-Busch Won’t Fund Controversial NIH Alcohol Study
  3. North American Universities Increasingly Cancel Publisher Packages
  4. CRISPR Efficiency Tied to Cancer-Causing Process